Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma

Volume: 125, Pages: 83 - 93
Published: Jan 1, 2020
Abstract
In recent years, new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC) including 5-fluorouracil, leucovorin, irinotecan and oxaliplatin. The impact hereof has not been assessed in nationwide cohort studies. This population-based study aimed to investigate nationwide trends in incidence, treatment and survival of PDAC.Patients with PDAC (1997-2016) were included from the Netherlands Cancer Registry. Results were...
Paper Details
Title
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
Published Date
Jan 1, 2020
Volume
125
Pages
83 - 93
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.